[HTML][HTML] The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year …

S Qin, GJ Liu, M Huang, J Huang, Y Luo… - International Journal …, 2018 - Taylor & Francis
Purpose: To investigate the clinical effectiveness and safety of ultrasound (US)-guided
percutaneous microwave ablation (MWA) for colorectal liver metastasis (CRLM) and …

[HTML][HTML] Advances in non-surgical management of primary liver cancer

X Chen, HP Liu, M Li, L Qiao - World Journal of Gastroenterology …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most
common cause of cancer-related death worldwide. There have been great improvements in …

Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis

X Yin, BH Zhang, SJ Qiu, ZG Ren, J Zhou… - Annals of surgical …, 2012 - Springer
Background Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an
uncommon subtype of primary liver cancer that has rarely been reported in large-scale …

Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study

TW Kang, HK Lim, MW Lee, Y Kim, H Rhim, WJ Lee… - Radiology, 2016 - pubs.rsna.org
Purpose To compare the long-term therapeutic outcomes of radiofrequency (RF) ablation for
hepatocellular carcinoma (HCC) in subcapsular versus nonsubcapsular locations by using …

[HTML][HTML] Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with …

X Yin, L Zhang, YH Wang, BH Zhang, YH Gan, NL Ge… - BMC cancer, 2014 - Springer
Background This study was designed to evaluate the effectiveness of radiofrequency
ablation in patients with intermediate (BCLC B) stage hepatocellular carcinoma who …

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study

I Bargellini, R Sacco, E Bozzi, M Bertini… - European journal of …, 2012 - Elsevier
AIM: To assess clinical outcome of transarterial chemoembolization (TACE) in a series of
patients with early-stage hepatocellular carcinoma (HCC), within Milan criteria, but clinically …

Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score–matched study

H Zheng, K Liu, Y Yang, B Liu, X Zhao, Y Chen… - European …, 2022 - Springer
Objectives Thermal ablation is now accepted as one of the curative treatments for patients
with early-stage hepatocellular carcinoma (HCC), but the efficacy of this treatment for …

Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score–matched study of long-term therapeutic outcomes

K Liu, H Zheng, X Sui, B Liu, M Meng, Y Feng, Q Zhu… - European …, 2023 - Springer
Objectives The therapeutic efficacy of microwave ablation (MWA) for subcapsular
hepatocellular carcinoma (HCC) has not been well characterized. We aimed to compare the …

[HTML][HTML] Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of …

K Chen, MX Zhan, BS Hu, Y Li, X He… - Oncology …, 2018 - spandidos-publications.com
The aim of the present study was to investigate the prognostic potential of a novel
inflammation‑based system, the combination of the neutrophil to lymphocyte ratio (NLR) and …

Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods

JD Liang, XO Ping, YJ Tseng, GT Huang, F Lai… - Computer methods and …, 2014 - Elsevier
Background and objective Recurrence of hepatocellular carcinoma (HCC) is an important
issue despite effective treatments with tumor eradication. Identification of patients who are at …